The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes

The Journal of Biological Chemistry
Jeffrey H TeckmanDavid H Perlmutter

Abstract

Because retention of mutant alpha(1)-antitrypsin (alpha(1)-AT) Z in the endoplasmic reticulum (ER) is associated with liver disease in alpha(1)-AT-deficient individuals, the mechanism by which this aggregated glycoprotein is degraded has received considerable attention. In previous studies using stable transfected human fibroblast cell lines and a cell-free microsomal translocation system, we found evidence for involvement of the proteasome in degradation of alpha(1)-ATZ (Qu, D., Teckman, J. H., Omura, S., and Perlmutter, D. H. (1996) J. Biol. Chem. 271, 22791-22795). In more recent studies, Cabral et al. (Cabral, C. M., Choudhury, P., Liu, Y., and Sifers, R. N. (2000) J. Biol. Chem. 275, 25015-25022) found that degradation of alpha(1)-ATZ in a stable transfected murine hepatoma cell line was inhibited by tyrosine phosphatase inhibitors, but not by the proteasomal inhibitor lactacystin and concluded that the proteasome was only involved in ER degradation of alpha(1)-ATZ in nonhepatocytic cell types or in cell types with levels of alpha(1)-AT expression that are substantial lower than that which occurs in hepatocytes. To examine this important issue in further detail, in this study we established rat and murine hepatoma cell lin...Continue Reading

References

Jun 10, 1976·The New England Journal of Medicine·T Sveger
Apr 1, 1989·The Journal of Clinical Investigation·J A CarlsonS L Woo
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y WuD H Perlmutter
Jul 12, 1997·Lancet·R W Carrell, D A Lomas
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·P Rollini, R E Fournier
Sep 26, 2000·American Journal of Physiology. Cell Physiology·R K StuderC H Evans

❮ Previous
Next ❯

Citations

Jun 15, 2007·Lung·Alan T MulgrewN Gerry McElvaney
Mar 3, 2006·Current Gastroenterology Reports·Jeffrey H Teckman, Douglas Lindblad
Apr 4, 2003·The International Journal of Biochemistry & Cell Biology·Helen ParfreyDavid A Lomas
Jul 2, 2008·The Journal of Experimental Medicine·Bibek Gooptu, David A Lomas
Mar 23, 2011·Cold Spring Harbor Perspectives in Biology·David H Perlmutter, Gary A Silverman
Jun 1, 2004·Thorax·D A Lomas, H Parfrey
Dec 5, 2002·The Journal of Clinical Investigation·David A Lomas, Ravi Mahadeva
Dec 5, 2002·The Journal of Clinical Investigation·David H Perlmutter
Sep 17, 2005·The Journal of Clinical Investigation·Ann M KennedyRajesh V Thakker
Aug 27, 2010·The Journal of Clinical Investigation·S Tamir RashidLudovic Vallier
Jun 1, 2010·Experimental Biology and Medicine·Shalesh KaushalJeffrey H Teckman
Dec 18, 2013·Current Gastroenterology Reports·Jeffrey H Teckman, Ajay Jain
Jul 20, 2014·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Abdulrahman Al-HussainiFrancesco Callea
Jul 30, 2014·Future Medicinal Chemistry·Mun Peak Nyon, Bibek Gooptu
Apr 5, 2005·Methods : a Companion to Methods in Enzymology·Daniel TermineRichard N Sifers
Aug 27, 2009·Biologics : Targets & Therapy·Caitriona McLeanNoel G McElvaney
Feb 20, 2008·The Journal of Cell Biology·Beat NyfelerHans-Peter Hauri
Jul 30, 2014·Expert Review of Gastroenterology & Hepatology·Jeffrey H Teckman, Nisha Mangalat
Dec 2, 2006·COPD·Roberta J Navickis, Mahlon M Wilkes
Aug 30, 2005·Critical Reviews in Biochemistry and Molecular Biology·Eelco van Anken, Ineke Braakman
Dec 10, 2015·Human Molecular Genetics·Riccardo RonzoniAnna Maria Fra
Dec 25, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jae-Koo AnJeffrey H Teckman
Mar 19, 2013·Transplantation Proceedings·M L Schilsky
Oct 20, 2010·Best Practice & Research. Clinical Gastroenterology·Robert Bals
Feb 25, 2010·Seminars in Cell & Developmental Biology·Tiziana Anelli, Roberto Sitia
Jul 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David A Rudnick, David H Perlmutter
Sep 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Paola FrancalanciFrancesco Callea
May 16, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shujuan PanRichard N Sifers
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David A RudnickJeffrey H Teckman
Dec 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Adriana OrdóñezDavid A Lomas
Jun 13, 2012·Clinical and Translational Science·Nicholas Maurice, David H Perlmutter
Oct 7, 2004·Clinics in Liver Disease·David H Perlmutter
Oct 16, 2014·Molecular Neurobiology·Zhiping HuHan Xiao
Mar 23, 2010·Respiratory Medicine·Emer KellyShane J O'Neill
Dec 1, 2010·Methods : a Companion to Methods in Enzymology·Didier BelorgeyDavid A Lomas
Jul 29, 2016·Nature Reviews. Disease Primers·Catherine M GreeneNoel G McElvaney
Oct 23, 2016·Free Radical Biology & Medicine·Andrea Di FrancescoRafael de Cabo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.